Position in GRFS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$78,411
-$43,669 QoQ
Shares Held
11,075
-27.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#105
of 164 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026QUADRANT CAPITAL GROUP LLC holds $116,130,341 across 15 Drug Manufacturers - General names. GRFS ranks #15 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,147 | $24,164,918 | |
| 2 | JNJ |
Johnson & Johnson
|
77,048 | $19,567,880 | |
| 3 | ABBV |
AbbVie Inc.
|
56,848 | $14,305,230 | |
| 4 | MRK |
Merck & Co., Inc.
|
88,627 | $11,388,569 | |
| 5 | AZN |
Astrazeneca PLC
|
50,534 | $9,582,257 | |
| 6 | NVS |
Novartis AG
|
61,000 | $9,559,920 | |
| 7 | AMGN |
Amgen Inc
|
16,658 | $6,032,194 | |
| 8 | NVO |
Novo Nordisk A S
|
115,512 | $5,537,645 |
All Filings in GRFS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,411 | 11,075 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $122,080 | 15,222 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $143,073 | 15,302 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $152,407 | 15,302 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $138,330 | 15,302 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $119,248 | 16,772 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $48,791 | 6,558 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $59,602 | 6,712 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $22,886 | 3,627 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $37,267 | 5,579 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $72,504 | 6,272 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $56,777 | 6,212 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $56,471 | 6,165 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $43,121 | 5,851 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $41,301 | 4,859 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $19,440 | 3,156 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $149,711 | 12,602 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $186,214 | 15,943 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $133,064 | 11,849 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $52,420 | 3,588 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $87,808 | 5,061 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $87,746 | 5,075 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $106,361 | 5,768 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $96,951 | 5,588 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $50,816 | 2,786 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $377,896 | 18,764 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||